{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T07:43:18Z","timestamp":1778226198000,"version":"3.51.4"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004061","name":"Oesterreichische Nationalbank","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004061","id-type":"DOI","asserted-by":"crossref"}]},{"name":"The Austrian Science Fund"},{"name":"The National Human Genome Research Institute"},{"name":"NIH"},{"DOI":"10.13039\/100000863","name":"The Ellison Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000863","id-type":"DOI","asserted-by":"crossref"}]},{"name":"The Dana-Farber Cancer Institute Strategic Initiative"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.canlet.2016.11.034","type":"journal-article","created":{"date-parts":[[2016,12,7]],"date-time":"2016-12-07T03:01:56Z","timestamp":1481079716000},"page":"158-166","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Comparative transcriptome analysis links distinct peritoneal tumor spread types, miliary and non-miliary, with putative origin, tubes and ovaries, in high grade serous ovarian cancer"],"prefix":"10.1016","volume":"388","author":[{"given":"Katharina","family":"Auer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Bachmayr-Heyda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefanie","family":"Aust","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas W.","family":"Grunt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8355-0977","authenticated-orcid":false,"given":"Dietmar","family":"Pils","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2016.11.034_bib1","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.ajog.2004.02.067","article-title":"Intraperitoneal serous adenocarcinoma: a critical appraisal of three hypotheses on its cause","volume":"191","author":"Piek","year":"2004","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.canlet.2016.11.034_bib2","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/path.1000","article-title":"Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer","volume":"195","author":"Piek","year":"2001","journal-title":"J.\u00a0Pathol."},{"key":"10.1016\/j.canlet.2016.11.034_bib3","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0090-8258(03)00365-2","article-title":"BRCA1\/2-related ovarian cancers are of tubal origin: a hypothesis","volume":"90","author":"Piek","year":"2003","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.canlet.2016.11.034_bib4","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1046\/j.1365-2559.2001.01042.x","article-title":"Precursor lesions of ovarian epithelial malignancy","volume":"38","author":"Feeley","year":"2001","journal-title":"Histopathology"},{"key":"10.1016\/j.canlet.2016.11.034_bib5","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1200\/JCO.2006.07.9970","article-title":"Early events in the pathogenesis of epithelial ovarian cancer","volume":"26","author":"Landen","year":"2008","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.canlet.2016.11.034_bib6","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/PGP.0b013e3181f45f3e","article-title":"The origin of ovarian carcinomas: a unifying hypothesis,","volume":"30","author":"Auersperg","year":"2011","journal-title":"Int. J. Gynecol. Pathol."},{"key":"10.1016\/j.canlet.2016.11.034_bib7","doi-asserted-by":"crossref","first-page":"709","DOI":"10.2741\/S401","article-title":"The origin of ovarian cancers\u2013hypotheses and controversies","volume":"5","author":"Auersperg","year":"2013","journal-title":"Front. Biosci. (Schol Ed)"},{"key":"10.1016\/j.canlet.2016.11.034_bib8","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/GCO.0b013e328011a21f","article-title":"The distal fallopian tube: a new model for pelvic serous carcinogenesis,","volume":"19","author":"Crum","year":"2007","journal-title":"Curr. Opin. Obstet. Gynecol."},{"key":"10.1016\/j.canlet.2016.11.034_bib9","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/01.pas.0000180854.28831.77","article-title":"The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome","volume":"30","author":"Medeiros","year":"2006","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.canlet.2016.11.034_bib10","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/01.pas.0000213335.40358.47","article-title":"Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: evidence for a causal relationship","volume":"31","author":"Kindelberger","year":"2007","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.canlet.2016.11.034_bib11","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.ygyno.2010.11.020","article-title":"\u201cPrimary peritoneal\u201d high-grade serous carcinoma is very likely metastatic from serous tubal intraepithelial carcinoma: assessing the new paradigm of ovarian and pelvic serous carcinogenesis and its implications for screening for ovarian cancer","volume":"120","author":"Seidman","year":"2011","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.canlet.2016.11.034_bib12","first-page":"3","article-title":"Pathogenesis of serous, extra-uterine Mullerian epithelial cancer and therapeutic implications","volume":"4","author":"Dubeau","year":"2015","journal-title":"Transl. Cancer Res."},{"key":"10.1016\/j.canlet.2016.11.034_bib13","doi-asserted-by":"crossref","first-page":"39640","DOI":"10.18632\/oncotarget.9243","article-title":"Small RNAs and the competing endogenous RNA network in high grade serous ovarian cancer tumor spread","volume":"7","author":"Bachmayr-Heyda","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2016.11.034_bib14","doi-asserted-by":"crossref","first-page":"17261","DOI":"10.18632\/oncotarget.3746","article-title":"Peritoneal tumor spread in serous ovarian cancer-epithelial mesenchymal status and outcome","volume":"6","author":"Auer","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2016.11.034_bib15","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.11038","article-title":"Role of the immune system in the peritoneal tumor spread of high grade serous ovarian cancer","author":"Auer","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2016.11.034_bib16","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ccr.2014.05.002","article-title":"Hematogenous metastasis of ovarian cancer: rethinking mode of spread","volume":"26","author":"Pradeep","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2016.11.034_bib17","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ygyno.2015.08.017","article-title":"Beyond genomics: critical evaluation of cell line utility for ovarian cancer research","volume":"139","author":"Elias","year":"2015","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.canlet.2016.11.034_bib18","doi-asserted-by":"crossref","DOI":"10.1111\/j.1349-7006.2012.02306.x","article-title":"Validating the impact of a molecular subtype in ovarian cancer on outcomes: a study of the OVCAD Consortium","author":"Pils","year":"2012","journal-title":"Cancer Sci."},{"key":"10.1016\/j.canlet.2016.11.034_bib19","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ejca.2013.09.011","article-title":"Cyclin E1 (CCNE1) as independent positive prognostic factor in advanced stage serous ovarian cancer patients \u2013 a study of the OVCAD consortium","volume":"50","author":"Pils","year":"2014","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.canlet.2016.11.034_bib20","doi-asserted-by":"crossref","first-page":"7547","DOI":"10.1073\/pnas.1017300108","article-title":"Modeling high-grade serous ovarian carcinogenesis from the fallopian tube","volume":"108","author":"Karst","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.canlet.2016.11.034_bib21","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1038\/nprot.2012.097","article-title":"Primary culture and immortalization of human fallopian tube secretory epithelial cells","volume":"7","author":"Karst","year":"2012","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.canlet.2016.11.034_bib22","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1002\/ijc.22300","article-title":"Multiple roles of the candidate oncogene ZNF217 in ovarian epithelial neoplastic progression","volume":"120","author":"Li","year":"2007","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.canlet.2016.11.034_bib23","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1002\/ijc.29261","article-title":"Fatty acid synthase is a metabolic marker of cell proliferation rather than malignancy in ovarian cancer and its precursor cells","volume":"136","author":"Veigel","year":"2015","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.canlet.2016.11.034_bib24","doi-asserted-by":"crossref","first-page":"e97","DOI":"10.1093\/nar\/gkv412","article-title":"Why weight? Modelling sample and observational level variability improves power in RNA-seq analyses","volume":"43","author":"Liu","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.canlet.2016.11.034_bib25","doi-asserted-by":"crossref","first-page":"e6098","DOI":"10.1371\/journal.pone.0006098","article-title":"Deconvolution of blood microarray data identifies cellular activation patterns in systemic lupus erythematosus","volume":"4","author":"Abbas","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.canlet.2016.11.034_bib26","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1093\/bioinformatics\/btt351","article-title":"CellMix: a comprehensive toolbox for gene expression deconvolution","volume":"29","author":"Gaujoux","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.canlet.2016.11.034_bib27","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1111\/j.1349-7006.2009.01204.x","article-title":"Gene expression profiling of advanced-stage serous ovarian cancers distinguishes novel subclasses and implicates ZEB2 in tumor progression and prognosis","volume":"100","author":"Yoshihara","year":"2009","journal-title":"Cancer Sci."},{"key":"10.1016\/j.canlet.2016.11.034_bib28","doi-asserted-by":"crossref","first-page":"e24","DOI":"10.1371\/journal.pmed.1000024","article-title":"Survival-related profile, pathways, and transcription factors in ovarian cancer","volume":"6","author":"Crijns","year":"2009","journal-title":"PLoS Med."},{"key":"10.1016\/j.canlet.2016.11.034_bib29","doi-asserted-by":"crossref","first-page":"e30269","DOI":"10.1371\/journal.pone.0030269","article-title":"Angiogenic mRNA and microRNA gene expression signature predicts a novel subtype of serous ovarian cancer","volume":"7","author":"Bentink","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.canlet.2016.11.034_bib30","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1002\/path.4536","article-title":"Efficient molecular subtype classification of high-grade serous ovarian cancer","volume":"236","author":"Leong","year":"2015","journal-title":"J.\u00a0Pathol."},{"key":"10.1016\/j.canlet.2016.11.034_bib31","doi-asserted-by":"crossref","first-page":"5198","DOI":"10.1158\/1078-0432.CCR-08-0196","article-title":"Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome","volume":"14","author":"Tothill","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2016.11.034_bib32","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/nature10166","article-title":"Integrated genomic analyses of ovarian carcinoma","volume":"474","author":"TCGA","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2016.11.034_bib33","series-title":"Modern Applied Statistics with S","author":"Venables","year":"2003"},{"key":"10.1016\/j.canlet.2016.11.034_bib34","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/bioinformatics\/btn577","article-title":"A\u00a0novel signaling pathway impact analysis,","volume":"25","author":"Tarca","year":"2009","journal-title":"Bioinformatics"},{"key":"10.1016\/j.canlet.2016.11.034_bib35","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1093\/bioinformatics\/btt285","article-title":"Pathview: an R\/Bioconductor package for pathway-based data integration and visualization","volume":"29","author":"Luo","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.canlet.2016.11.034_bib36","doi-asserted-by":"crossref","first-page":"D447","DOI":"10.1093\/nar\/gku1003","article-title":"STRING v10: protein-protein interaction networks, integrated over the tree of life","volume":"43","author":"Szklarczyk","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.canlet.2016.11.034_bib37","first-page":"64","article-title":"The 'dnet' approach promotes emerging research on cancer patient survival,","volume":"6","author":"Fang","year":"2014","journal-title":"Genome Med."},{"key":"10.1016\/j.canlet.2016.11.034_bib38","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.humpath.2015.03.017","article-title":"PAX8 expression in ovarian surface epithelial cells","volume":"46","author":"Adler","year":"2015","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.canlet.2016.11.034_bib39","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1053\/S0046-8177(03)00339-3","article-title":"Calretinin expression in human normal and neoplastic tissues: a tissue microarray analysis on 5233 tissue samples","volume":"34","author":"Lugli","year":"2003","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.canlet.2016.11.034_bib40","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.ygyno.2013.03.021","article-title":"Ovarian surface epithelium as a source of ovarian cancers: unwarranted speculation or evidence-based hypothesis?","volume":"130","author":"Auersperg","year":"2013","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.canlet.2016.11.034_bib41","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ygyno.2006.08.052","article-title":"Emerging roles for PAX8 in ovarian cancer and endosalpingeal development","volume":"104","author":"Bowen","year":"2007","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.canlet.2016.11.034_bib42","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/modpathol.2011.3","article-title":"PAX 8 expression in non-neoplastic tissues, primary tumors, and metastatic tumors: a comprehensive immunohistochemical study","volume":"24","author":"Ozcan","year":"2011","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.canlet.2016.11.034_bib43","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1158\/1078-0432.CCR-13-1256","article-title":"A\u00a0collagen-remodeling gene signature regulated by TGF-beta signaling is associated with metastasis and poor survival in serous ovarian cancer","volume":"20","author":"Cheon","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2016.11.034_bib44","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/nbt.3080","article-title":"A\u00a0comprehensive transcriptional portrait of human cancer cell lines","volume":"33","author":"Klijn","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.canlet.2016.11.034_bib45","doi-asserted-by":"crossref","first-page":"12645","DOI":"10.1038\/ncomms12645","article-title":"Integrative proteomic profiling of ovarian cancer cell lines reveals precursor cell associated proteins and functional status","volume":"7","author":"Coscia","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2016.11.034_bib46","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1136\/jclinpath-2014-202430","article-title":"Caution over use of ES2 as a model of ovarian clear cell carcinoma","volume":"67","author":"Kwok","year":"2014","journal-title":"J.\u00a0Clin. Pathol."},{"key":"10.1016\/j.canlet.2016.11.034_bib47","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1038\/ncomms3126","article-title":"Evaluating cell lines as tumour models by comparison of genomic profiles","volume":"4","author":"Domcke","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2016.11.034_bib48","doi-asserted-by":"crossref","first-page":"6571","DOI":"10.3390\/ijms14046571","article-title":"The molecular fingerprint of high grade serous ovarian cancer reflects its fallopian tube origin","volume":"14","author":"Kessler","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.canlet.2016.11.034_bib49","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1038\/onc.2014.136","article-title":"Epithelial-mesenchymal status renders differential responses to cisplatin in ovarian cancer","volume":"34","author":"Miow","year":"2015","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2016.11.034_bib50","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ygyno.2012.06.012","article-title":"Pair Box 8 (PAX8) protein expression in high grade, late stage (stages III and IV) ovarian serous carcinoma","volume":"127","author":"Mhawech-Fauceglia","year":"2012","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.canlet.2016.11.034_bib51","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1757-2215-6-31","article-title":"Nadir CA-125 level as prognosis indicator of high-grade serous ovarian cancer","volume":"6","author":"Xu","year":"2013","journal-title":"J.\u00a0Ovarian Res."},{"key":"10.1016\/j.canlet.2016.11.034_bib52","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1757-2215-2-13","article-title":"Role of CA125 in predicting ovarian cancer survival - a review of the epidemiological literature","volume":"2","author":"Gupta","year":"2009","journal-title":"J.\u00a0Ovarian Res."},{"key":"10.1016\/j.canlet.2016.11.034_bib53","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.ygyno.2006.09.028","article-title":"CA125 expression pattern, prognosis and correlation with serum CA125 in ovarian tumor patients. From the Danish \u201cMALOVA\u201d Ovarian Cancer Study","volume":"104","author":"Hogdall","year":"2007","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.canlet.2016.11.034_bib54","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.86829","article-title":"Mutant p53 regulates ovarian cancer transformed phenotypes through autocrine matrix deposition","volume":"1","author":"Iwanicki","year":"2016","journal-title":"JCI Insight"},{"key":"10.1016\/j.canlet.2016.11.034_bib55","article-title":"Abstract PR08: evidence for extra-ovarian origin and peritoneal metastases that precede ovarian carcinomas in high-grade serous ovarian cancer","volume":"22","author":"Chien","year":"2016","journal-title":"Am. Assoc. Cancer Res."},{"key":"10.1016\/j.canlet.2016.11.034_bib56","doi-asserted-by":"crossref","DOI":"10.1158\/1541-7786.MCR-16-0097","article-title":"DNA methylome analyses implicate fallopian tube epithelia as the origin for high-grade serous ovarian cancer","author":"Klinkebiel","year":"2016","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.canlet.2016.11.034_bib57","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1038\/bjc.2014.443","article-title":"Intra- and postoperative catumaxomab in patients with epithelial ovarian cancer: safety and two-year efficacy results from a multicentre, single-arm, phase II study","volume":"111","author":"Sehouli","year":"2014","journal-title":"Br. J. Cancer"}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030438351630739X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030438351630739X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,27]],"date-time":"2019-04-27T14:42:43Z","timestamp":1556376163000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S030438351630739X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":57,"alternative-id":["S030438351630739X"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2016.11.034","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative transcriptome analysis links distinct peritoneal tumor spread types, miliary and non-miliary, with putative origin, tubes and ovaries, in high grade serous ovarian cancer","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2016.11.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}